Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease

Oral Diseases

Volumn 13, Issue 4, 2007, Pages 376-385

  Riccia, D N Della ^a   Bizzini, F ^a   Perilli, M G ^b   Polimeni, A ^c   Trinchieri, V ^c   Amicosante, G ^b   Cifone, M G ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

interferon; L. brevis; Metalloproteinases; Nitric oxide; Prostaglandin E2

Indexed keywords

ARGININE DEIMINASE; GAMMA INTERFERON; IMMUNOGLOBULIN A; METALLOPROTEINASE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; PROBIOTIC AGENT; PROSTAGLANDIN E2; SPIRAMYCIN;

ADULT; ANALYTICAL PARAMETERS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; LACTOBACILLUS BREVIS; LOZENGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERIODONTAL DISEASE; PERIODONTAL EXAMINATION; PRIORITY JOURNAL; RADIOMETRY; RANDOMIZED CONTROLLED TRIAL; RAT; SALIVA ANALYSIS; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DINOPROSTONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROLASES; IMMUNOGLOBULIN A, SECRETORY; INTERFERON TYPE II; LACTOBACILLUS BREVIS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PERIODONTAL INDEX; PERIODONTITIS; RATS; RATS, WISTAR; SALIVA;

EID: 34250667810     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01291.x     Document Type: Article

References (50)

1. Baron AC, Gansky SA, Ryder MI et al (1999). Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients. J Periodontal Res 34 : 437 444.
2. Bodana AR, Rao DR (1990). Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. J Dairy Sci 73 : 3379 3384.
3. Çaglar E, Kargul B, Tanboga I (2005). Bacteriotherapy and probiotics' role on oral health. Oral Dis 11 : 131 137.
4. Cavanaugh PF JR., Meredith MP, Buchanan W et al (1998). Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse. J Periodontal Res 33 : 75 82.
5. Cifone MG, D'alò S, Parroni R et al (1999). Interleukin-2- activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. Blood 93 : 3876 3884.
6. Daghigh F, Borghaei RC, Thornton RD et al (2002). Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 73 : 392 400.
7. Di Marzio L, Russo PF, Biordi L et al (2001). Apoptotic effects of selected strains of lactic acid bacteria on a human T leukaemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer 40 : 185 196.
8. Ding Y, Uitto VJ, Firth J et al (1995). Modulation of host matrix metalloproteinases by bacterial virulence factors relevant in human periodontal diseases. Oral Dis 1 : 279 286.
9. Dugas B, Mercenier A, Lenoir-Wijnkoop I et al (1999). Immunity and probiotics. Immunol Today 20 : 387 390.
10. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S et al (2003). Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2 : 188 195.
11. Golub LM, Ryan ME, Williams RC (1998). Modulation of the host response in the treatment of periodontitis. Dent Today 17 : 102 106.
12. Goodwin DC, Landino LM, Marnett LJ (1999). Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J 13 : 1121 1136.
13. Gorbach SL (2000). Probiotics and gastrointestinal health. Am J Gastroenterol 95 (Suppl. 1 S2 S4.
14. Graves DT (1999). The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28 : 482 490.
15. Grudianov AI, Dmitrieva NA, Fomenko EV (2002). Use of probiotics Bifidumbacterin and Acilact in tablets in therapy of periodontal inflammation. Stomatologiia Mosk 81 : 39 43.
16. Henskens YM, Van Den Keijbus PA, Veeman EC et al (1996). Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J Periodontol Res 31 : 57 65.
17. Hirai Y, Migita K, Honda S et al (2001). Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells. Life Sci 68 : 913 920.
18. Hirose M, Ishihara K, Saito A et al (2001). Expression of cytokines and inducible nitric oxide synthase inflamed gingival tissue. J Periodontol 72 : 590 597.
19. Ishii Y, Ogura T, Tatemichi M et al (2003). Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int J Cancer 103 : 161 168.
20. Kendall HK, Marshall RI, Bartold PM (2001). Nitric oxide and tissue destruction. Oral Dis 7 : 2 10.
21. Konings WN, Kok J, Kuipers OP et al (2000). Lactic acid bacteria: the bugs of the new millennium. Curr Opin Microbiol 3 : 276 282.
22. Kornman KS (1999). Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 28 : 520 526.
23. Korostoff JM, Wang JF, Sarment DP et al (2000). Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 71 : 353 360
24. Lappin DF, Kjeldsen M, Sander L et al (2000). Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 35 : 369 373.
25. Leibur E, Tuhkanen A, Pintson U et al (1999). Prostaglandin E2 levels in blood plasma and in crevicular fluid of advanced periodontitis patients before and after surgical therapy. Oral Dis 5 : 223 228.
26. Lohinai Z, Benedek P, Feher E et al (1998). Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 123 : 353 357.
27. Lohinai Z, Stachlewitz R, Virag L et al (2001). Evidence for reactive nitrogen species formation in the gingivomucosal tissue. J Dental Res 80 : 470 475.
28. Maeda H, Okamoto T, Akaike T (1998). Human matrix metalloproteinase activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 379 : 193 200.
29. Makela M, Salo T, Uitto VJ et al (1994). Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dental Res 73 : 1397 1406.
30. Matejka M, Partyka L, Ulm C et al (1998). Nitric oxide synthesis is increased in periodontal disease. J Periodontal Res 33 : 517 518.
31. Matejka M, Ulm C, Partyka L et al (1999). Nitric oxide synthesis is increased in periodontitis. Adv Exp Med Biol 469 : 419 424.
32. McGee JM, Tucci MA, Edmundson TP et al (1998). The relationship between concentrations of proinflammatory cytokines within gingival and the adjacent sulcural depth. J Periodontol 69 : 865 871.
33. Offenbacher S (1996). Periodontal diseases: pathogenesis. Ann Periodontol 1 : 821 878.
34. Paquette DW, Williams RC (2000). Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 24 : 239 252.
35. Roberfroid MB (1998). Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 80 : S197 S220.
36. Schenk K, Poppelsdorf D, Denis C et al (1993). Levels of salivary IgA antibodies reactive with bacteria from dental plaque are associated with susceptibility to experimental gingivitis. J Clin Periodontol 20 : 411 417.
37. Silness J, Löe H (1964). Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22 : 121 135.
38. Smith SI, Aweh AJ, Coker AO et al (2001). Lactobacilli in human dental caries and saliva. Microbios 105 : 77 85.
39. Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 6 : 311 318 (Review).
40. Takeichi O, Haber J, Kawai T et al (2000). Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res 79 : 1548 1555.
41. Tervahartiala T, Koski H, Xu JW et al (2001). Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 80 : 1684 1687.
42. Thorgeirsson UP, MacKay AR (1992). Characterization of metastatic tumor cell. In : Gallegner CT, Rees RC, Reynolds CW, eds. Tumor immunology: a practical approach. University Press : Oxford, pp. 82 90.
43. Travis J, Potemba J (2000). Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta 1477 : 35 50.
44. Tronc F, Mallat Z, Lehoux S et al (2000). Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 20 : E120 E126.
45. Tsai CC, Hong CC, Chen CC et al (1998). Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 26 : 97 103.
46. Tsilingaridis G, Yucel-Lindberg T, Modeer T (2003). Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 3 : 154 158.
47. Ukai T, Mori Y, Onoyama M et al (2001). Immunohistological study of interferon-gamma- and interleukin-4-bearing cells in human periodontitis gingival. Arch Oral Biol 46 : 901 908.
48. Volozhin AI, Il'in VK, Maksimovskii IuM et al (2004). Development and use of periodontal dressing of collagen and Lactobacillus casei 37 cell suspension in combined treatment of periodontal disease of inflammatory origin (a microbiological study). Stomatologiia (Mosk) 83 : 6 8
49. Weikmann JL, Himmel ME, Smith DW et al (1978a). Arginine deiminase: demonstration of two active sites and possible half-of-the-sites reactivity. Biochem Biophys Res Commun 83 : 107 113.
50. Weikmann L, Himmel ME, Squire PG et al (1978b). Arginine deiminase from Mycoplasma arthritidis. Properties of the enzyme from log phase cultures. J Biol Chem 253 : 6010 6015.